Eicosapentaenoic Acid [bacs, lipd, phsu]
Efficacy [qlco]
Colorectal [spco]
Aberrant Crypt Foci [fndg]
Aberrant Crypt Foci [fndg]
DOUBLE BLIND [resa]
randomized controlled trial [inpr, resa]
Background [cnce]
Colorectal Cancer [neop]
One [qnco]
Most [qnco]
Occur [acty]
Neoplasms [neop]
Leading [tmco]
Cancer [neop]
Death [orgf]
New [tmco]
preventive [ftcn]
strategies [menp]
Needed [qlco]
To [qlco]
Lower [spco]
Burden [idcn]
Disease [dsyn]
Eicosapentaenoic Acid [bacs, lipd, phsu]
Eicosapentaenoic Acid [bacs, lipd, phsu]
treatment [ftcn]
Hyperlipidaemia [dsyn]
Prevention [topp]
Cardiovascular disease [dsyn]
Recently [tmco]
Suggest [idcn]
To [qlco]
Suppressive [ftcn]
Effect [qlco]
Tumorigenesis [neop]
Cancer Cell Growth [neop]
Colorectal [spco]
cancer chemoprevention [topp]
Trial [resa]
General [spco]
Incidence [qnco]
polyps [anab]
Cancer [neop]
Set [menp]
Study [mnob]
End Point [qlco]
Incidence Rate [qnco]
Colorectal Cancer [neop]
Most [qnco]
Reliability [qnco]
End Point [qlco]
End Point [qlco]
Chemoprevention [topp]
Trial [resa]
low [qlco]
occurrence [ftcn]
Rate [acty]
Colorectal Cancer [neop]
General Population [popg]
Long-term [tmco]
Observation [resa]
ethical [idcn]
Problem [fndg]
conducting [inbe]
Long-term [tmco]
Trial [resa]
test drug [lbpr]
effective [qlco]
Aberrant Crypt Foci [fndg]
Defined [cnce]
lesions [fndg]
Containing [ftcn]
Crypt [bpoc]
larger [qnco]
Diameter [qnco]
Stain [irda]
More [ftcn]
Methylene blue [irda, orch, phsu]
Normal [qlco]
Crypt [bpoc]
considered [idcn]
Reliability [qnco]
Biomarker [clna]
Colorectal Cancer [neop]
prospective [resa]
randomized controlled trial [inpr, resa]
Preliminary [tmco]
Study [mnob]
Colorectal Cancer [neop]
Chemoprevention [topp]
Trial [resa]
Evaluate [ftcn]
Chemopreventive [qlco]
Effect [qlco]
Eicosapentaenoic Acid [bacs, lipd, phsu]
Colorectal [spco]
Aberrant Crypt Foci [fndg]
formation [biof]
Safety [hcpp]
Drug [phsu]
Patients [podg]
Scheduled [inpr]
Polypectomy [topp]
Methods [inpr]
This [euka]
Study [mnob]
DOUBLE BLIND [resa]
placebo-controlled [resa]
randomized controlled trial [inpr, resa]
Conduct [inbe]
Patients [podg]
Colorectal [spco]
Aberrant Crypt Foci [fndg]
Colorectal polyps [neop]
Scheduled [inpr]
Polypectomy [topp]
eligible [idcn]
Patients [podg]
Study [mnob]
Aberrant Crypt Foci [fndg]
Rectum [bpoc]
Count [acty]
Baseline Colonoscopy [hlca]
Then [tmco]
participants [popg]
One [qnco]
Two [qnco]
Group [idcn]
Eicosapentaenoic Acid [bacs, lipd, phsu]
Group [idcn]
placebo [topp]
Group [idcn]
Patients [podg]
Eicosapentaenoic Acid [bacs, lipd, phsu]
Group [idcn]
Receive [qlco]
Oral Capsule [bodm]
mg% [qnco]
Eicosapentaenoic Acid [bacs, lipd, phsu]
Daily [tmco]
Total Daily Dose [qnco]
g% [qnco]
placebo [topp]
Group [idcn]
Receive [qlco]
Oral Capsule [bodm]
placebo [topp]
Daily [tmco]
One [qnco]
month [tmco]
treatment [ftcn]
Eicosapentaenoic Acid [bacs, lipd, phsu]
placebo [topp]
Colonoscopies [diap]
Polypectomy [topp]
Performed [ftcn]
To [qlco]
Evaluate [ftcn]
formation [biof]
Aberrant Crypt Foci [fndg]
Cell Proliferative Activity [lbtr]
Cell [cell]
Apoptotic [qlco]
activity [dora]
Normal [qlco]
Colorectal [spco]
Mucosa [tisu]
Colorectal polyps [neop]
Discussion [topp]
This [euka]
First [qnco]
Study [mnob]
PROPOSED [idcn]
To [qlco]
Effect [qlco]
Eicosapentaenoic Acid [bacs, lipd, phsu]
Colorectal [spco]
Aberrant Crypt Foci [fndg]
formation [biof]
Humans [humn]
This [euka]
Trial [resa]
Registered [hlca]
university hospital [hcro, mnob]
Medical [ftcn]
Network, Information [mnob]
Clinical Trials [resa]
Registry [inpr]
